KCM
NBSE

Knoll Capital Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Knoll Capital Management’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
2016
Q4 		$306K Sell
2016
Q3 		$568K Hold
2016
Q2 		$562K Hold
2016
Q1 		$658K Hold
2015
Q4 		$1.26M Hold
2015
Q3 		$566K Hold
2015
Q2 		$515K Hold
2015
Q1 		$521K Buy